Glaxo Smith Kline (BIOC)

• Stock
• Company Profile
• News
• Announcements
• Fair Values
• Corporate Actions
• Earning Announcements
• News Reports
• Insider Trades
• Volume Statistics
• Financial Ratios
• IPOs
• Financial Statements
• Support and resistance
• More

General Information

Company Name Glaxo Smith Kline (BIOC)

Company Purpose Glaxo SmithKline is a public company, listed on Egyptian Exchange (EGX) since October 1985. It operates within the Pharmaceuticals, Biotechnology and Life Sciences sector focusing on Pharmaceuticals. Glaxo SmithKline is based in Cairo, Egypt and was established in January 1981.

Company Establish Date 14 January 1981

Financial Year Start First Quarter

Auditor

• Baker Tilly - Wahid Abdel Ghaffar and Co

Ownership

• Glaxo Group Ltd (91.20%)
• Qatar National Bank (5.89%)

Management

Samer Mohamed Talaat Fahim Al Falaki Chairman Represents Glaxo Group Ltd

Munir Ghabbour Hanna Board Members

Sherif Mohamed Mohamed Amin Saleh Board Members Represents Glaxo Group Ltd

Heba Al Murshidy Board Members Represents Glaxo Group Ltd

Omar Sameh Shoukry Board Members Represents Glaxo Group Ltd

Mohammad Ali Abdul Azim Board Members Represents Glaxo Group Ltd

Laila Daniel Shaker Boles Board Members Represents Glaxo Group Ltd

Omnia Saad Abd El Rahman Kelig Board Members

Shirin Al Ansary Board Members Represents Qatar National Bank

Sara Mohamed Hassan Mohamed Board Members

Subsidiaries

• Amoun Pharmaceutical Industries (99.64%)
• Modern Pharma International (20.00%)

Contacts

Address Boomerang Building, No. 46, Zone (J), 5th Settlement, 11835, P.O. Box 41, New Cairo

Phone +20 2 26185000

Fax +20 2 26185001

Website www.gsk.com/en-gb/locations/egypt

Email

Contact Person Omar Sameh Shoukry